Literature DB >> 12532575

Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype.

M Iqbal1, I K Patel, S H Shah, Q Ain, N Barney, Q Kiani, K Z Rabbani, G Zaidi, B Mehdi.   

Abstract

OBJECTIVE: To study Escherichia coli (E. coli) susceptibility, prevalence of multidrug-resistant isolates and possible role of extended spectrum beta-lactamases (ESBL) in E. coli resistance.
SETTING: Department of Medicine, Shifa College of Medicine, Islamabad.
METHODS: Three hundred and seventy eight E. coli isolates from different sources were identified during six-month period. Susceptibility to various antibiotics was checked using standard methods. Multidrug-resistant isolates were separated. Isolates resistant to cefpodoxime and aztreonam were considered as ESBL phenotype, indicating ESBL production.
RESULTS: Most of isolates were resistant to ampicillin and trimethoprim/sulfamethoxazole. Overall resistance to ciprofloxacin, ceftriaxone, cefotaxime and cefpodoxime was 49%, 34%, 36% and 38% respectively. Resistance to fourth generation cephalosporins was lower. Almost all Isolates were sensitive to amikacin, imipenem and tazobactam. Aztreonam resistance was found in 25% isolates. Similar pattern was observed for urinary E. coli isolates; 45% E. coli isolates were found to be multidrug-resistant. Nitrofurantoin showed low-level resistance both to multidrug-resistant as well as urinary isolates. Resistance to both cefpodoxime and aztreonam was found in 25% isolates suggesting ESBL production.
CONCLUSION: E. coli resistance in Pakistan is much higher than reported from western literature. Multidrug-resistant isolates, including third generation cephalosporins and quinolones, are very common. ESBL production may contribute to this high level resistance against beta-lactams.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12532575

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  4 in total

1.  Resistant plasmid profile analysis of multidrug resistant Escherichia coli isolated from urinary tract infections in Abeokuta, Nigeria.

Authors:  O Akingbade; S Balogun; D Ojo; P Akinduti; P O Okerentugba; J C Nwanze; I O Okonko
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia.

Authors:  M Kibret; B Abera
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

3.  Virulence Genes and Antimicrobial Resistance Pattern in Uropathogenic Escherichia coli Isolated From Hospitalized Patients in Kashan, Iran.

Authors:  Foroogh Neamati; Farzaneh Firoozeh; Mahmood Saffari; Mohammad Zibaei
Journal:  Jundishapur J Microbiol       Date:  2015-02-07       Impact factor: 0.747

4.  Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.

Authors:  Samyyia Abrar; Shahida Hussain; Rehan Ahmad Khan; Noor Ul Ain; Hayat Haider; Saba Riaz
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-20       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.